 | Up a level |
Jolidon, Vladimir; Eicher, Manuela; Peytremann-Bridevaux, Isabelle; Aebi, Stefan; Anchisi, Sandro; Bettini, Adrienne; Chalandon, Yves; Dietrich, Pierre-Yves; Duchosal, Michel A; Dürr, Donat; Peters, Solange; von Moos, Roger; Wicki, Andreas; Arditi, Chantal (2024). Identifying the drivers of overall rating of cancer care: Insights from the second wave of the Swiss Cancer Patient Experiences study. (In Press). Cancer Wiley 10.1002/cncr.35506
Wapnir, Irene L.; Price, Karen N.; Anderson, Stewart J.; Robidoux, André; Martín, Miguel; Nortier, Johan W.R.; Paterson, Alexander H.G.; Rimawi, Mothaffar F.; Láng, István; Baena-Cañada, José Manuel; Thürlimann, Beat; Mamounas, Eleftherios P.; Geyer, Charles E.; Gelber, Shari; Coates, Alan S.; Gelber, Richard D.; Rastogi, Priya; Regan, Meredith M.; Wolmark, Norman and Aebi, Stefan (2018). Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial. Journal of clinical oncology, 36(11), pp. 1073-1079. American Society of Clinical Oncology 10.1200/JCO.2017.76.5719
Zander, T; Aebi, Stefan; Pabst, T; Renner, C; Driessen, C (2017). Spotlight on pomalidomide: could less be more? Leukemia, 31(9), pp. 1987-1989. Nature Publishing Group 10.1038/leu.2017.156
Hamzic, Seid; Wenger, N; Fröhlich, Tanja; Joerger, M; Aebi, Stefan; Largiadèr, Carlo Rodolfo; Amstutz, Ursula (2017). The impact of ABCC11 polymorphisms on the risk of early-onset fluoropyrimidine toxicity. Pharmacogenomics journal, 17(4), pp. 319-324. Nature Publishing Group 10.1038/tpj.2016.23
Kummer, Dominic; Fröhlich, Tanja; Joerger, Markus; Aebi, Stefan; Sistonen, Johanna; Amstutz, Ursula; Largiadèr, Carlo Rodolfo (2015). Dihydropyrimidinase and β-ureidopropionase gene variation and severe fluoropyrimidine-related toxicity. Pharmacogenomics, 16(12), pp. 1367-1377. Future Medicine 10.2217/pgs.15.81
Decensi, Andrea; Sun, Zhuoxin; Guerrieri-Gonzaga, Aliana; Thürlimann, Beat; McIntosh, Christina; Tondini, Carlo; Monnier, Alain; Campone, Mario; Debled, Marc; Schönenberger, Astrid; Zaman, Khalil; Johansson, Harriet; Price, Karen N; Gelber, Richard D.; Goldhirsch, Aron; Coates, Alan S.; Aebi, Stefan (2014). Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences. Breast cancer research and treatment, 144(2), pp. 321-329. Springer 10.1007/s10549-014-2849-2
Aebi, Stefan; Gelber, Shari; Anderson, Stewart J.; Láng, István; Robidoux, André; Martín, Miguel; Nortier, Johan W. R.; Paterson, Alexander H. G.; Rimawi, Mothaffar F.; Cañada, José Manuel Baena; Thürlimann, Beat; Murray, Elizabeth; Mamounas, Eleftherios P.; Geyer, Charles E.; Price, Karen N.; Coates, Alan S.; Gelber, Richard D.; Rastogi, Priya; Wolmark, Norman and Wapnir, Irene L. (2014). Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. The lancet oncology, 15(2), pp. 156-163. Elsevier 10.1016/S1470-2045(13)70589-8
Burmeister, H; Aebi, S; Studer, C; Fey, M.F.; Gautschi, O (2012). Adherence to ESMO clinial recommendations for prophylaxis of chemotherapy-induced nausea and vomiting. Supportive care in cancer, 20(1), pp. 141-7. Berlin: Springer 10.1007/s00520-010-1079-3
Zaman, K; Thürlimann, B; Huober, J; Schönenberger, A; Pagani, O; Lüthi, J; Simcock, M; Giobbie-Hurder, A; Berthod, G; Genton, C; Brauchli, P; Aebi, S (2012). Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07). Annals of oncology, 23(6), pp. 1474-1481. Oxford University Press 10.1093/annonc/mdr448
Moor, A E; Guevara, C; Altermatt, H J; Warth, R; Jaggi, R; Aebi, S (2011). PRO_10--a new tissue-based prognostic multigene marker in patients with early estrogen receptor-positive breast cancer. Pathobiology, 78(3), pp. 140-8. Basel: Karger 10.1159/000323809
Huober, Jens; Baumann, Michael; Rochlitz, Christoph; Aebi, Stefan; Güth, Uwe; von Moos, Roger; Müller, Andreas; von Rohr, Lukas; Widmer, Isabelle; Thürlimann, Beat (2011). Trastuzumab treatment beyond progression in advanced breast cancer: patterns of care in six Swiss breast cancer centers. Oncology - international journal of cancer research and treatment, 81(3-4), pp. 160-166. Karger 10.1159/000333396
Aebi, S; Davidson, T; Gruber, G; Cardoso, F (2011). Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 22(Suppl 6), vi12-24. Oxford University Press 10.1093/annonc/mdr371
Antonov, Janine; Popovici, Vlad; Delorenzi, Mauro; Wirapati, Pratyaksha; Baltzer, Anna; Oberli, Andrea; Thürlimann, Beat; Giobbie-Hurder, Anita; Viale, Giuseppe; Altermatt, Hans Jörg; Aebi, Stefan; Jaggi, Rolf (2010). Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue. BMC cancer, 10, p. 37. London: BioMed Central 10.1186/1471-2407-10-37
Aebi, S.; Davidson, T.; Gruber, G.; Castiglione, M. (2010). Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology, 21(Suppl.), pp. 9-14. Oxford: Oxford University Press 10.1093/annonc/mdq159
Diel, Ingo; Aebi, Stefan (2010). Routine adjuvant use of bisphosphonates in breast cancer arguments in favour and against. Critical reviews in oncology, hematology, 74 Suppl 1, S11-S15. Boca Raton, Fla.: Elsevier
Farese, Simone Anna; Aebi, Stefan (2009). Infiltrating Lobular Carcinoma of the Breast: Systemic Treatment. Breast disease, 30, pp. 45-52. Amsterdam: IOS Press
Aebi, Stefan (2009). The voice of a special patient. Cancer Treatment and Research, 151, pp. 461-466. New York, N.Y.: Springer Science+Business Media
Aebi, Stefan; Castiglione, Monica (2009). Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology, 20(Suppl 4), pp. 21-23. Oxford: Oxford University Press 10.1093/annonc/mdp117
Gelber, Richard D; Aebi, Stefan (2009). Endocrine therapy plus zoledronic acid in premenopausal breast cancer. New England journal of medicine NEJM, 360(22), 2367; author reply 2369-70. Waltham, Mass.: Massachusetts Medical Society MMS
Colleoni, M; Sun, Z; Martinelli, G; Basser, R L; Coates, A S; Gelber, R D; Green, M D; Peccatori, F; Cinieri, S; Aebi, S; Viale, G; Price, K N; Goldhirsch, A (2009). The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up. Annals of oncology, 20(8), pp. 1344-51. Oxford: Oxford University Press 10.1093/annonc/mdp024
Amstutz, Ursula; Farese, Simone; Aebi, Stefan; Largiadèr, Carlo R (2008). Hypermethylation of the DPYD promoter region is not a major predictor of severe toxicity in 5-fluorouracil based chemotherapy. Clinical cancer research, 27(1), p. 54. Philadelphia, Pa.: American Association for Cancer Research 10.1186/1756-9966-27-54
Bartholomeyczik, S; Schnell, M; Aebi, S (2008). [Effectiveness of specialized nursing for patients with breast cancer and other gynecologic cancers: a prospective, longitudinal, two-arm pilot study in Switzerland]. Pflege - die wissenschaftliche Zeitschrift für Pflegeberufe, 21(5), pp. 353-4. Bern: H. Huber 10.1024/1012-5302.21.5.353
Aebi, S; Loibl, S (2008). Breast cancer during pregnancy: medical therapy and prognosis. Recent results in cancer research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 178, pp. 45-55. Berlin: Springer
Bernhard, J; Zahrieh, D; Zhang, J J; Martinelli, G; Basser, R; Hürny, C; Forbes, J F; Aebi, S; Yeo, W; Thürlimann, B; Green, M D; Colleoni, M; Gelber, R D; Castiglione-Gertsch, M; Price, K N; Goldhirsch, A; Coates, A S (2008). Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer. British journal of cancer, 98(1), pp. 25-33. Basingstoke: Nature Publishing Group 10.1038/sj.bjc.6604092
Wapnir, Irene L; Aebi, Stefan; Gelber, Shari; Anderson, Stewart J; Láng, István; Robidoux, André; Mamounas, Eleftherios P; Wolmark, Norman (2008). Progress on BIG 1-02/IBCSG 27-02/NSABP B-37, a prospective randomized trial evaluating chemotherapy after local therapy for isolated locoregional recurrences of breast cancer. Annals of surgical oncology, 15(11), pp. 3227-31. New York, N.Y.: Springer 10.1245/s10434-008-0129-2
Wapnir, Irene L; Aebi, Stefan; Geyer, Charles E; Zahrieh, David; Gelber, Richard D; Anderson, Stewart J; Robidoux, André; Bernhard, Jürg; Maibach, Rudolf; Castiglione-Gertsch, Monica; Coates, Alan S; Piccart, Martine J; Clemons, Mark J; Costantino, Joseph P; Wolmark, Norman (2008). A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37. Clinical breast cancer, 8(3), pp. 287-92. New York, N.Y.: Elsevier 10.3816/CBC.2008.n.035
Aebi, S; Castiglione, M (2008). Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of oncology, 19 Suppl 2, ii14-6. Oxford: Oxford University Press 10.1093/annonc/mdn073
Lorenzo, Gianni; Cole, Bernard F; Panzini, Ilaria; Snyder, Raymond; Holmberg, Stig B; Byrne, Michael; Crivellari, Diana; Colleoni, Marco; Aebi, Stefan; Simoncini, Edda; Pagani, Olivia; Castiglione-Gertsch, Monica; Price, Karen N; Goldhirsch, Aron; Coates, Alan S; Ravaioli, Alberto (2008). Anemia during adjuvant non-taxane chemotherapy for early breast cancer: Incidence and risk factors from two trials of the International Breast Cancer Study Group. Supportive care in cancer, 16(1), pp. 67-74. Berlin: Springer 10.1007/s00520-007-0295-y
Oberli, Andrea; Popovici, Vlad; Delorenzi, Mauro; Baltzer, Anna; Antonov, Janine; Matthey, Sybille; Aebi, Stefan; Altermatt, Hans Jörg; Jaggi, Rolf (2008). Expression profiling with RNA from formalin-fixed, paraffin-embeeded material. BMC Genomics, 1(1), p. 9. London: BioMed Central 10.1186/1755-8794-1-9
Harter, P; Aebi, S; Hilpert, F; du Bois, A (2008). Primär- und Rezidivtherapie des Ovarialkarzinoms. Onkologe, 14(11), pp. 1140-1150. Heidelberg: Springer-Medizin-Verlag 10.1007/s00761-008-1473-3
Eicher, M; Aebi, S (2008). Breast Care Nurses: Erstes Deutschsprachiges Lehrbuch erschienen. Schweizer Krebsbulletin / Bulletin suisse du cancer(4), p. 297. Bellinzona: Istituto oncologico della Svizzera Italiana
Bernhard, J; Zahrieh, D; Castiglione-Gertsch, M; Hürny, C; Gelber, RD; Forbes, JF; Murray, E; Collins, J; Aebi, S; Thürlimann, B; Price, KN; Goldhirsch, A; Coates, AS; International, Breast Cancer Study Group Trial VIII (2007). Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII. Journal of clinical oncology, 25(3), pp. 263-70. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.04.5393
Rabaglio, Manuela; Aebi, Stefan; Castiglione-Gertsch, Monica (2007). Controversies of adjuvant endocrine treatment for breast cancer and recommendations of the 2007 St Gallen conference. Lancet oncology, 8(10), pp. 940-9. Oxford: Elsevier 10.1016/S1470-2045(07)70317-0
Aebi, Stefan; Pagani, Olivia (2007). Treatment of premenopausal women with early breast cancer: old challenges and new opportunities. Drugs, 67(10), pp. 1393-401. Auckland (NZ): Adis International 10.2165/00003495-200767100-00002
Keshaviah, A; Dellapasqua, S; Rotmensz, N; Lindtner, J; Crivellari, D; Collins, J; Colleoni, M; Thürlimann, B; Mendiola, C; Aebi, S; Price, K N; Pagani, O; Simoncini, E; Castiglione Gertsch, M; Gelber, R D; Coates, A S; Goldhirsch, A (2007). CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials. Annals of oncology, 18(4), pp. 701-8. Oxford: Oxford University Press 10.1093/annonc/mdl492
Aebi, S; Castiglione, M (2006). The enigma of young age. Annals of oncology, 17(10), pp. 1475-7. Oxford: Oxford University Press 10.1093/annonc/mdl330
Eicher, Manuela R E; Marquard, Sara; Aebi, Stefan (2006). A nurse is a nurse? A systematic review of the effectiveness of specialised nursing in breast cancer. European journal of cancer, 42(18), pp. 3117-26. Amsterdam: Elsevier 10.1016/j.ejca.2006.07.007
Colleoni, M; Gelber, S; Goldhirsch, A; Aebi, S; Castiglione-Gertsch, M; Price, KN; Coates, AS; Gelber, RD; International, Breast Cancer Study Group (2006). Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93. Journal of clinical oncology, 24(9), pp. 1332-41. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.03.0783
Basser, RL; O'Neill, A; Martinelli, G; Green, MD; Peccatori, F; Cinieri, S; Coates, AS; Gelber, RD; Aebi, S; Castiglione-Gertsch, M; Viale, G; Price, KN; Goldhirsch, A; International, Breast Cancer Study Group (2006). Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95. Journal of clinical oncology, 24(3), pp. 370-8. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2005.03.5196
Aebi, Stefan (2006). Chemotherapy - overview and future perspectives. Breast, 2(15), S11-4. Amsterdam: Elsevier
Gick, Ute; Rochlitz, Christoph; Mingrone, Walter; Pestalozzi, Bernhard; Rauch, Daniel; Ballabeni, Pierluigi; Lanz, Doris; Hess, Viviane; Aebi, Stefan (2006). Efficacy and tolerability of capecitabine with weekly paclitaxel for patients with metastatic breast cancer: a phase II report of the SAKK. Oncology - international journal of cancer research and treatment, 71(1-2), pp. 54-60. Basel: Karger 10.1159/000100449
Kaiser, P C; Körner, M; Kappeler, A; Aebi, S (2005). Retinoid receptors in ovarian cancer: expression and prognosis. Annals of oncology, 16(9), pp. 1477-1487. Oxford University Press 10.1093/annonc/mdi265
Aebi, Stefan (2004). Endometrial cancer: a frequent orphan disease. Annals of oncology, 15(8), pp. 1149-1150. Oxford University Press 10.1093/annonc/mdh325
Kralidis, E.; Aebi, S.; Friess, H.; Büchler, M. W.; Borner, M. M. (2003). Activity of raltitrexed and gemcitabine in advanced pancreatic cancer. Annals of oncology, 14(4), pp. 574-579. Oxford University Press 10.1093/annonc/mdg150
Novak, Urban; Grob, T. J.; Baskaynak, G.; Peters, U. R.; Aebi, Stefan; Zwahlen, D.; Tschan, Mario; Kreuzer, K.-A.; Oppliger Leibundgut, Elisabeth; Cajot, J.-F.; Tobler, Andreas; Fey, Martin (2001). Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia. Annals of oncology, 12(7), pp. 981-986. Oxford University Press 10.1023/A:1011153206003
Aebi, S.; Castiglione-Gertsch, M. (2001). High-dose chemotherapy for ovarian cancer: Are we ready to go? Annals of oncology, 12(5), pp. 583-584. Oxford University Press 10.1023/A:1011134312452
Buetler, T. M.; Wilder-Smith, O. H. G.; Wilder-Smith, C. H.; Aebi, S.; Cerny, T.; Brenneisen, R. (2000). Analgesic action of i.v. morphine-6-glucuronide in healthy volunteers. British journal of anaesthesia, 84(1), pp. 97-99. Oxford University Press 10.1093/oxfordjournals.bja.a013391
Zahnd, D.; Aebi, S.; Rusterholz, S.; Fey, M. F.; Borner, M. M. (1999). A randomized crossover trial assessing patient preference for two different types of portable infusion-pump devices. Annals of oncology, 10(6), pp. 727-729. Oxford University Press 10.1023/A:1008334313918
